secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0001558370-23-007667
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Virios Therapeutics gets Nasdaq bid-price extension to Oct 30, 2023
-------------------------------------------------------------------

- Received extension letter on May 2, 2023; new compliance period ends Oct 30, 2023.
- Company meets all other Nasdaq listing requirements except $1.00 minimum bid price.
- Intends to cure deficiency via reverse stock split if necessary.
- If not compliant by Oct 30, 2023, Nasdaq could delist; company may appeal to Hearings Panel.
- No assurance of regaining compliance or maintaining Nasdaq listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023007667/0001558370-23-007667-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023007667/tmb-20230502x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-007667

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer